BRIEF-Profusa Expands Into Multi-Billion Dollar Precision Diagnostics Market With $30M Letter Of Intent For A Panomics Platform

Reuters04-06 18:45

April 6 (Reuters) - Profusa Inc PFSA.O:

PROFUSA EXPANDS INTO MULTI-BILLION DOLLAR PRECISION DIAGNOSTICS MARKET WITH $30M LETTER OF INTENT FOR A PANOMICS PLATFORM
PROFUSA INC - UNDER LETTER OF INTENT, BIOINSIGHTS TO RECEIVE 3% ROYALTY ON NET REVENUE

Source text: ID:nGNE3TFPmp

Further company coverage: PFSA.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2625675441?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-06 18:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2625675441","market":"nz","top_or_hot":-1,"title":"BRIEF-Profusa Expands Into Multi-Billion Dollar Precision Diagnostics Market With $30M Letter Of Intent For A Panomics Platform","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Profusa Expands Into Multi-Billion Dollar Precision Diagnostics Market With $30M Letter Of Intent For A Panomics Platform</title></head><body><p><span>April 6 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/PFSA\">Profusa Inc</a> <span>PFSA.O</span>:</p><ul><li><p>PROFUSA EXPANDS INTO MULTI-BILLION DOLLAR PRECISION DIAGNOSTICS MARKET WITH $30M LETTER OF INTENT FOR A PANOMICS PLATFORM</p></li><li><p>PROFUSA INC -  UNDER LETTER OF INTENT, BIOINSIGHTS TO RECEIVE 3% ROYALTY ON NET REVENUE</p></li></ul><p>Source text: <span>ID:nGNE3TFPmp</span></p><p>Further company coverage: <span>PFSA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Profusa Expands Into Multi-Billion Dollar Precision Diagnostics Market With $30M Letter Of Intent For A Panomics Platform</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Profusa Expands Into Multi-Billion Dollar Precision Diagnostics Market With $30M Letter Of Intent For A Panomics Platform\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-04-06 18:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Profusa Expands Into Multi-Billion Dollar Precision Diagnostics Market With $30M Letter Of Intent For A Panomics Platform</title></head><body><p><span>April 6 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/PFSA\">Profusa Inc</a> <span>PFSA.O</span>:</p><ul><li><p>PROFUSA EXPANDS INTO MULTI-BILLION DOLLAR PRECISION DIAGNOSTICS MARKET WITH $30M LETTER OF INTENT FOR A PANOMICS PLATFORM</p></li><li><p>PROFUSA INC -  UNDER LETTER OF INTENT, BIOINSIGHTS TO RECEIVE 3% ROYALTY ON NET REVENUE</p></li></ul><p>Source text: <span>ID:nGNE3TFPmp</span></p><p>Further company coverage: <span>PFSA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nFWN40N03O:1","article_id":"2625675441","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2625675441","pubTimestamp":1775472326,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Profusa Expands Into Multi-Billion Dollar Precision Diagnostics Market With $30M Letter Of Intent For A Panomics PlatformApril 6 (Reuters) - Profusa Inc PFSA.O:PROFUSA EXPANDS INTO MULTI-BILLION","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","PFSA":"Profusa Inc"},"translate_title":"简介-Profusa凭借价值3000万美元的Panomics平台意向书扩展到价值数十亿美元的精密诊断市场","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFSA":0.9},"content_text":"BRIEF-Profusa Expands Into Multi-Billion Dollar Precision Diagnostics Market With $30M Letter Of Intent For A Panomics PlatformApril 6 (Reuters) - Profusa Inc PFSA.O:PROFUSA EXPANDS INTO MULTI-BILLION DOLLAR PRECISION DIAGNOSTICS MARKET WITH $30M LETTER OF INTENT FOR A PANOMICS PLATFORMPROFUSA INC -  UNDER LETTER OF INTENT, BIOINSIGHTS TO RECEIVE 3% ROYALTY ON NET REVENUESource text: ID:nGNE3TFPmpFurther company coverage: PFSA.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2625675441","isCrawlerRequest":true}